DiscoverThe Weight Loss PodcastFDA reverses decision to halt compounding of Terzepetide, for now
FDA reverses decision to halt compounding of Terzepetide, for now

FDA reverses decision to halt compounding of Terzepetide, for now

Update: 2024-10-28
Share

Description

Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

FDA reverses decision to halt compounding of Terzepetide, for now

FDA reverses decision to halt compounding of Terzepetide, for now